These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. Kato T; Takahashi S; Shioiri T; Inubushi T J Affect Disord; 1993 Jan; 27(1):53-9. PubMed ID: 8432961 [TBL] [Abstract][Full Text] [Related]
6. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549 [TBL] [Abstract][Full Text] [Related]
7. Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS. Kato T; Shioiri T; Takahashi S; Inubushi T J Affect Disord; 1991 Aug; 22(4):185-90. PubMed ID: 1658103 [TBL] [Abstract][Full Text] [Related]
8. Regionally Distinct Alterations in Membrane Phospholipid Metabolism in Schizophrenia: A Meta-analysis of Phosphorus Magnetic Resonance Spectroscopy Studies. Haszto CS; Stanley JA; Iyengar S; Prasad KM Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Mar; 5(3):264-280. PubMed ID: 31748123 [TBL] [Abstract][Full Text] [Related]
9. Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. Kato T; Takahashi S; Shioiri T; Inubushi T J Affect Disord; 1992 Dec; 26(4):223-30. PubMed ID: 1479134 [TBL] [Abstract][Full Text] [Related]
10. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. Kato T; Takahashi S; Shioiri T; Murashita J; Hamakawa H; Inubushi T J Affect Disord; 1994 Jun; 31(2):125-33. PubMed ID: 8071475 [TBL] [Abstract][Full Text] [Related]
11. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. Fukuzako H World J Biol Psychiatry; 2001 Apr; 2(2):70-82. PubMed ID: 12587188 [TBL] [Abstract][Full Text] [Related]
12. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease. Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496 [TBL] [Abstract][Full Text] [Related]
13. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Yildiz-Yesiloglu A; Ankerst DP Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):969-95. PubMed ID: 16677749 [TBL] [Abstract][Full Text] [Related]
14. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Silverstone PH; McGrath BM; Kim H Bipolar Disord; 2005 Feb; 7(1):1-10. PubMed ID: 15654927 [TBL] [Abstract][Full Text] [Related]
15. 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain. Komoroski RA; Pearce JM; Mrak RE Magn Reson Med; 2008 Mar; 59(3):469-74. PubMed ID: 18306399 [TBL] [Abstract][Full Text] [Related]
16. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Yacubian J; de Castro CC; Ometto M; Barbosa E; de Camargo CP; Tavares H; Cerri GG; Gattaz WF Schizophr Res; 2002 Dec; 58(2-3):117-22. PubMed ID: 12409151 [TBL] [Abstract][Full Text] [Related]
17. A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder. Brady RO; Cooper A; Jensen JE; Tandon N; Cohen B; Renshaw P; Keshavan M; Öngür D Transl Psychiatry; 2012 Sep; 2(9):e160. PubMed ID: 22968227 [TBL] [Abstract][Full Text] [Related]